HIMS 这一页 8 条观点条目，其中 0 条方向发生变化。
就我个人而言，我最喜欢的两只便宜股票，让我再加上第三只，是SoFi、American Airlines和Hims。
Personally, my two favorite cheap stocks, well let me add a third, are SoFi, American Airlines, and Hims.
我想谈谈“Hems & Hers Health”这家公司。这是另一个备受关注的名称，尤其是在社交媒体上。它是一只波动较大的股票，但似乎正处于过渡阶段，我很想知道你对它在这个领域所扮演角色的看法，以及你对这家公司的总体看法。
I want to talk about the company "Hems & Hers Health". This is another name that is attracting a lot of attention, especially on social media. It's a volatile stock, but it seems to be in a transitional phase, and I'm interested to know your opinion on its role in this area, and your general opinion of the company .
Hims & Hers 管理层向投资者重申了其长期业绩指引。管理层预计，到2030年营收至少达到65亿美元，调整后息税折旧摊销前利润达到13亿美元。
Hims & Hers management team reiterated its longer-term guidance to investors. The management team is forecasting at least $6.5 billion in revenue by 2030 and $1.3 billion in adjusted earnings before interest, taxes, depreciation, and amortization.
但这是否意味着 Hims & Hers 的股票对长期投资者来说是一个买入机会？因此，到2030年营收至少达到60亿美元，将是其最近12个月营收总额的两倍多。在这一时期，Hims & Hers 报告的营收为26亿美元。
这较2020年的约2.5亿美元有所增长。这一直是全球增长最快的公司之一。
But does this make Hims & Hers stock a buying opportunity for long-term investors? So, revenue of at least $6 billion by 2030 would be more than double their most recent trailing 12-month total.
In that period, Hims & Hers reported $2.6 billion in revenue. That's up from around $250 million in 2020. This has been one of the fastest-growing companies in the world.
作为美国领先的远程医疗公司，对 Hims & Hers 来说可能是一个 10 倍的机会，甚至更大，但成为全球远程医疗公司——无论你身在何处，都能回答你所有问题的地方——才是医疗保健和 Hims & Hers 真正巨大的机会所在。
Being a leading telehealth company in the US could be a 10x, maybe even a bigger opportunity for Hims & Hers, but beating being the global telehealth company where you go to answer all your questions no matter where you are in the world is really where the massive opportunity is for healthcare and for Hims & Hers.
第一，我们将在本视频中讨论Hims股票，好吗？有一些关于Hims的消息传出来。股价大幅下跌。我想谈谈这个。
Number one, we're going to discuss Hims stock in this video, okay? There was some news that came out in regards to Hims. Stock went down heavy. I want to talk about that.
Hims股票今天在这里遭到重创，下跌约8%，对吧？对Hims股票来说是艰难的一天。在我观察名单上的股票中，你知道，4000xstocks.com，这是今天表现最差的。
Hims stock got hammered here today, down 8% roughly, right? Tough day for Hims stock. Of the stocks on my watchlist, you know, 4000xstocks.com, that was the worst performer here today.
Hims & Hers，尽管今年经历了这一切，实际上今年仍下跌近 20%，但你可以看到股价在 2 月底触底。自那以来，上涨近 100%，仅小幅回调。他们在 7 月初的交易价格接近每股 40 美元。
所以，自那以来，下跌约 25%。这是一只波动性很大的股票。所以，投资者需要记住这一点。
Hims & Hers, as for everything that it has gone through this year, is actually still down almost 20% for the year, but you can see shares bottomed in late February. Since then, up nearly 100% pulled back just a little bit.
They were trading at nearly $40 per share in early July. So, since then, down about 25%. Very volatile stock. So, something to keep in mind for investors.
但是，有一只我感兴趣想买入的股票，它就在我的观察名单上，那就是 Hims。Hims 的股票，明白吗？这是我可能想要建仓的一只股票，现在股价就在 30 美元多一点，对吧？而且我已经把它列入了我的买入观察名单，对吧？
But, there's is a stock that I've been interested in buying, and it's right on my watch list, and it is Hims. Hims stock, okay? This is one I've been interested in potentially starting a position, and it's 30, you know, just over $30 right now, right?
And I got it on my stocks to buy watch list, right?
今天，我第二次邀请 Paul Cerro 做客。Paul 经营 Cedar Grove Capital，他对 Hims 有一个投资论点。股票代码是 Hims。
today I've got Paul Cerro on for the second time. Paul runs Cedar Grove Capital and he has a thesis on Hims. The ticker is Hims.
他曾在一家 Hims 的竞争对手公司工作，因此他拥有实际的行业专业知识，而且他写过一篇分析，这是他第三次撰写并交易该股票。他做多该股取得了巨大成功，做空该股也取得了巨大成功，现在他又做多了。
He used to work for a Hims competitor, so he's got a you know, actual sector expertise and this is like he's done a write-up on This is his third time he's written up gone traded kind of quote-unquote traded the stock.
He went long the stock to great success. He went short the stock to great success and now he's long the stock again.
